Jasper Therapeutics(JSPR) - 2021 Q4 - Annual Report
Jasper Therapeutics(JSPR)2022-03-18 20:16☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) | Delaware | 84-2984849 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 2200 Bridge Pkwy Suite #102 | | | Redwood City, CA | 94065 | | (Address of principal executive offices) | (Zip Code) | | (650) 549-140 ...